awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35212678-5ABCFD62-42CF-46D3-8BCF-A1DA15D55520
Q35212678-5ABCFD62-42CF-46D3-8BCF-A1DA15D55520
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212678-5ABCFD62-42CF-46D3-8BCF-A1DA15D55520
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
P2860
Q35212678-5ABCFD62-42CF-46D3-8BCF-A1DA15D55520
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212678-5ABCFD62-42CF-46D3-8BCF-A1DA15D55520
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fd2789c6dda1a51a4645212864a3e674a7af191
P2860
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada